Brief: Bellicum Announces Clinical Hold Lifted On U.S. Studies Of BPX-501

Bellicum Pharmaceuticals

11/04/2018 22:01

April 11 (Reuters) - Bellicum Pharmaceuticals Inc  BLCM.O :
    * BELLICUM ANNOUNCES CLINICAL HOLD LIFTED ON U.S. STUDIES OF
BPX-501
    * FDA CLINICAL HOLD DID NOT AFFECT BP-004 REGISTRATIONAL
TRIAL IN
EUROPE, WHICH IS FULLY ENROLLED
    * LIFT OF CLINICAL HOLD FOLLOWS CONSULTATION WITH FDA &
AGREEMENT
ON AMENDMENTS TO STUDY PROTOCOLS
    * BELLICUM WILL BE WORKING WITH U.S. CLINICAL SITES TO
RESUME
PATIENT RECRUITMENT BASED ON AMENDED PROTOCOLS

Source text for Eikon:  ID:nGNX5NgtQr 
Further company coverage:  BLCM.O 

 ((Reuters.Briefs@thomsonreuters.com;))